Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Lymphoma 3Sarcoma 1Recurrence 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 9Melphalan 8X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 7Busulfan 7Flow Cytometry 6Filgrastim 6Nuclear Medicine Department, Hospital 5Methylprednisolone 5Carboplatin 5Biopsy 5Therapeutics 4Radiotherapy 4Psychiatric Rehabilitation 4Ipilimumab 4Etoposide 4Antilymphocyte Serum 4Alemtuzumab 4fludarabine 3Topotecan 3Thiotepa 3Stem Cell Transplantation 3Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Immunologic Techniques 3Crizotinib 3Caspofungin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × gallium nitrate × Lymphoid × Clear all
NCT00002543 2013-07-18

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
CNSLymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡